Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Profit After Tax (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Profit After Tax data on record, last reported at -$18.1 million in Q3 2025.

  • For Q3 2025, Profit After Tax rose 37.21% year-over-year to -$18.1 million; the TTM value through Sep 2025 reached -$47.6 million, up 61.4%, while the annual FY2024 figure was -$52.8 million, 36.7% up from the prior year.
  • Profit After Tax reached -$18.1 million in Q3 2025 per SNTI's latest filing, down from -$14.7 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$1178.0 in Q1 2021 and bottomed at -$71.1 million in Q4 2023.
  • Average Profit After Tax over 5 years is -$17.7 million, with a median of -$12.1 million recorded in 2024.
  • Peak YoY movement for Profit After Tax: tumbled 1002276.91% in 2022, then soared 99.16% in 2024.
  • A 5-year view of Profit After Tax shows it stood at -$3.9 million in 2021, then crashed by 1187.63% to -$49.7 million in 2022, then plummeted by 43.07% to -$71.1 million in 2023, then skyrocketed by 99.16% to -$600000.0 in 2024, then crashed by 2921.0% to -$18.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Profit After Tax were -$18.1 million in Q3 2025, -$14.7 million in Q2 2025, and -$14.1 million in Q1 2025.